These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 30738892)

  • 1. Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk.
    McQuade A; Blurton-Jones M
    J Mol Biol; 2019 Apr; 431(9):1805-1817. PubMed ID: 30738892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
    Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
    Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The age-related microglial transformation in Alzheimer's disease pathogenesis.
    Yuan C; Aierken A; Xie Z; Li N; Zhao J; Qing H
    Neurobiol Aging; 2020 Aug; 92():82-91. PubMed ID: 32408056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.
    Teter B; Morihara T; Lim GP; Chu T; Jones MR; Zuo X; Paul RM; Frautschy SA; Cole GM
    Neurobiol Dis; 2019 Jul; 127():432-448. PubMed ID: 30951849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease.
    Dos Santos LR; Pimassoni LHS; Sena GGS; Camporez D; Belcavello L; Trancozo M; Morelato RL; Errera FIV; Bueno MRP; de Paula F
    J Mol Neurosci; 2017 Jun; 62(2):215-221. PubMed ID: 28477215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD33 modulates TREM2: convergence of Alzheimer loci.
    Chan G; White CC; Winn PA; Cimpean M; Replogle JM; Glick LR; Cuerdon NE; Ryan KJ; Johnson KA; Schneider JA; Bennett DA; Chibnik LB; Sperling RA; Bradshaw EM; De Jager PL
    Nat Neurosci; 2015 Nov; 18(11):1556-8. PubMed ID: 26414614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies.
    Misra A; Chakrabarti SS; Gambhir IS
    Indian J Med Res; 2018 Aug; 148(2):135-144. PubMed ID: 30381536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis.
    Salminen A; Kaarniranta K; Kauppinen A
    Neurochem Int; 2021 Nov; 150():105186. PubMed ID: 34530055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2, microglia, and Alzheimer's disease.
    Qin Q; Teng Z; Liu C; Li Q; Yin Y; Tang Y
    Mech Ageing Dev; 2021 Apr; 195():111438. PubMed ID: 33516818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD33 isoforms in microglia and Alzheimer's disease: Friend and foe.
    Eskandari-Sedighi G; Jung J; Macauley MS
    Mol Aspects Med; 2023 Apr; 90():101111. PubMed ID: 35940942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2: Keeping Microglia Fit during Good Times and Bad.
    Hong S; Stevens B
    Cell Metab; 2017 Oct; 26(4):590-591. PubMed ID: 28978423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.
    Qu W; Li L
    Neuroscientist; 2023 Jun; 29(3):302-316. PubMed ID: 34470515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD33 in Alzheimer's disease.
    Jiang T; Yu JT; Hu N; Tan MS; Zhu XC; Tan L
    Mol Neurobiol; 2014 Feb; 49(1):529-35. PubMed ID: 23982747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
    Lue LF; Schmitz C; Walker DG
    Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function.
    Schlepckow K; Kleinberger G; Fukumori A; Feederle R; Lichtenthaler SF; Steiner H; Haass C
    EMBO Mol Med; 2017 Oct; 9(10):1356-1365. PubMed ID: 28855300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge.
    Nugent AA; Lin K; van Lengerich B; Lianoglou S; Przybyla L; Davis SS; Llapashtica C; Wang J; Kim DJ; Xia D; Lucas A; Baskaran S; Haddick PCG; Lenser M; Earr TK; Shi J; Dugas JC; Andreone BJ; Logan T; Solanoy HO; Chen H; Srivastava A; Poda SB; Sanchez PE; Watts RJ; Sandmann T; Astarita G; Lewcock JW; Monroe KM; Di Paolo G
    Neuron; 2020 Mar; 105(5):837-854.e9. PubMed ID: 31902528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD33 in Alzheimer's Disease - Biology, Pathogenesis, and Therapeutics: A Mini-Review.
    Zhao L
    Gerontology; 2019; 65(4):323-331. PubMed ID: 30541012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) as Expression of the Relationship between Microglia and Alzheimer's Disease: A Novel Marker for a Promising Pathway to Explore.
    Gussago C; Casati M; Ferri E; Arosio B
    J Frailty Aging; 2019; 8(2):54-56. PubMed ID: 30997915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.